DEVELOPMENT OF TDPI INHIBITORS BASED ON DERIVATIVES OF CHROMENE AS POTENTIAL ANTI-CANCER DRUGS



如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

全文:

受限制的访问

作者简介

A. Chepanova

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SBRAS

Email: arinachepanova@mail.ru
Russian Federation, Novosibirsk

N. Li-Zhulanov

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SBRAS; Novosibirsk State University

Russian Federation, Novosibirsk

T. Kurgina

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SBRAS

Russian Federation, Novosibirsk

A. Zakharenko

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SBRAS

Russian Federation, Novosibirsk

O. Zakharova

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SBRAS

Russian Federation, Novosibirsk

K. Volcho

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SBRAS; Novosibirsk State University

Russian Federation, Novosibirsk

N. Salakhutdinov

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SBRAS; Novosibirsk State University

Russian Federation, Novosibirsk

O. Lavrik

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SBRAS; Novosibirsk State University

Russian Federation, Novosibirsk

参考

  1. Interthal H et al., The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A. 2001;98(21):12009-14.
  2. Kamaletdinova T et al., The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers. Cells. 2019; 8(12),1625;
  3. Li-Zhulanov et al., A Novel Class of Tyrosyl-DNA Phosphodiesterase 1 Inhibitors That Contains the Octahydro-2H-chromen-4-ol Scaffold. Molecules, 2018, 23(10), 2468;

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-Vector, 2020



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 
##common.cookie##